Database IDs risk factors for iris damage, dropped nucleus
This article was reviewed by Mats. H. Lundstrom, MD
SUBSCRIBE: Print / Digital / eNewsletter
This article was reviewed by Mats. H. Lundstrom, MD
There is no argument with the old adage “practice makes perfect.” This is especially true for ophthalmology residents.
This article was reviewed by Yonca A. Akova
One of the most common questions I am asked by other surgeons is how to talk to patients about premium IOLs. It is so important to do this in an efficient but open, honest, and patient-centric way.
This article was reviewed by Florian Kretz, MD, FEBO
This article was reviewed by Davinder S. Grover, MD, MPH
This article was reviewed by David Chang, MD
Dislocation, decentration remain common issues; Accurate measurements, solid techniques can help
Speaking at AAO 2019, Ashraf El Habbak MD, PhD pointed out that bevacizumab inhibits vascular endothelial growth factor, which is a potent permeability factor implicated in cystoid macular edema.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.